Anxiogenic effects of Sumatriptan in panic disorder: A double-blind, placebo-controlled study

European Neuropsychopharmacology

Volumn 15, Issue 3, 2005, Pages 279-282

  Amital, Daniella ^a   Fostick, Leah ^a   Sasson, Yehuda ^a   Kindler, Seth ^a   Amital, Howard ^a   Zohar, Joseph ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Anxiety; Challenge test; PD; Serotonin; Sumatripan

Indexed keywords

SUMATRIPTAN;

ADULT; ANXIETY DISORDER; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HAMILTON SCALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

EID: 16844376277     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.12.002     Document Type: Article

References (21)

1. J.A. den Boer, and H.G. Westenberg Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder Psychiatry. Res. 31 1990 267 278
2. J.A. den Boer, and H.G. Westenberg Diagnostic aspects of anxiety disorders Acta Psychiatr. Belg. 90 1990 65 80
3. J.A. den Boer, and H.G. Westenberg Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin Psychopharmacology 102 1990 85 94
4. J.M. Gorman, M.R. Liebowitz, A.J. Fyer, and J. Stein A neuroanatomical hypothesis for panic disorder Am. J. Psychiatry 146 1989 148 161
5. Gross-Isseroff, R.G., Cohen, R., Sasson, Y., Voet, H. Zohar, J. Serotinergic dissection of obsessive compulsive symptoms: a challenge study with mCPP and Sumatriptan. Submitted for publication.
6. R.S. Kahn, G.M. Asnis, S. Wetzler, and H.M. van Praag Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder Psychopharmacology 96 1988 360 364
7. R.S. Kahn, H.M. van Praag, S. Wetzler, G.M. Asnis, and G. Barr Serotonin and anxiety revisited Biol. Psychiatry 23 1988 189 208
8. D.F. Klein, and H.M. Klein The utility of the panic disorder concept Eur. Arch. Psychiatr. Neurol. Sci. 238 1989 268 279
9. 1D receptors and obsessive-compulsive disorder Eur. Neuropsychopharmacol. 11 2001 169 172
10. V. Loi, M. Lai, M.R. Pisano, and M. Delzompo Sumatriptan and panic-like symptoms Am. J. Psychatr. 153 1996 1505
11. H.Y. Meltzer, and G.A. Gudelsky Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile Arzneimittelforschung 42 1992 268 272
12. A. Moulignier Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications Rev. Neurol. 150 1994 3 15
13. D.L. Murphy, and T.A. Pigott A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety J. Clin. Psychiatry 51 1990 53 58 (Suppl.)
14. D.L. Murphy, M.T. Pato, and T.A. Pigott Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents J. Clin. Psychopharmacol. 10 1990 91S 100S
15. 1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder Psychopharmacology (Berl.) 140 1998 365 370
16. M.A. Richter, L.J. Summerfeldt, M.M. Antony, and R.P. Swinson Obsessive-compulsive spectrum conditions in obsessive-compulsive disorder and other anxiety disorders Depress. Anxiety 18 2003 118 127
17. D.J. Stein, B. Van Heerden, and C.J. Wessels Single photon emission computed tomography of the brain with Tc-99 m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor Prog. Neuropsychopharmacol. Biol. Psychiatry 23 1999 1079 1099
18. S.D. Targum Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder Biol. Psychiatry 28 1990 21 34
19. S.D. Targum Mechanisms of anxiogenic vulnerability in panic disorder Psychiatry. Res. 31 1990 215 216
20. O. Tomkins, D. Kaufer, A. Korn, I. Shelef, H. Golan, E. Reichenthal, H. Soreq, and A. Friedman Frequent blood-brain barrier disruption in the human cerebral cortex Cell. Mol. Neurobiol. 21 2001 675 691
21. J. Zohar, E.A. Mueller, T.R. Insel, R.C. Zohar-Kadosh, and D.L. Murphy Serotonergic responsivity in obsessive compulsive disorder: comparison of patients and healthy controls Arch. Gen. Psychiatry. 44 1987 946 951